Go Pro
→ Why major institutions are piling into this digital asset now (From Awesomely) (Ad)tc pixel Free NVNO Stock Alerts

enVVeno Medical (NVNO) Earnings Date, Estimates & Call Transcripts

enVVeno Medical logo
$10.29 -0.10 (-0.96%)
As of 08/21/2026 03:34 PM Eastern
Compare

enVVeno Medical Earnings Summary

enVVeno Medical posted Q2 2026 earnings on July 30, 2026, reporting an EPS of -$5.37, which missed the consensus estimate of -$4.69 by $0.68. With a trailing EPS of -$19.33, enVVeno Medical's earnings are expected to grow next year, from ($16.19) to ($6.22) per share.

Q2 2026 Earnings Resources

NVNO Upcoming Earnings

enVVeno Medical's next earnings date is estimated for Friday, October 30, 2026, based on past reporting schedules.

Upcoming Q3
Earnings Date
Oct. 30After Market ClosesEstimated
Consensus EPS
(Jul. 30)
-$4.69
Actual EPS
(Jul. 30)
-$5.37 Missed By -$0.68
Get enVVeno Medical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on enVVeno Medical and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

NVNO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

enVVeno Medical Analyst EPS Estimates

Current Year EPS Consensus Estimate
($16.19) EPS
Next Year EPS Consensus Estimate
($6.22) EPS

enVVeno Medical Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/30/2026
(Estimated)		--------
7/30/2026Q2 2026-$4.69-$5.37 -$0.68-$5.37$1.00M-
5/7/2026Q1 2026-$8.40-$5.89+$2.51-$5.89$0.50M-
10/30/2025Q3 2025--$8.05--$0.23--
7/31/2025Q2 2025-$9.80-$11.55 -$1.75-$0.33--
4/30/2025Q1 2025--$7.70--$0.22--
2/27/2025Q4 2024-$12.25-$10.50+$1.75-$0.30--
10/31/2024--$11.55-$12.25 -$0.70-$0.35--

enVVeno Medical Earnings - Frequently Asked Questions

enVVeno Medical has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 30th, 2026 based off last year's report dates. Learn more on NVNO's earnings history.

In the previous quarter, enVVeno Medical (NASDAQ:NVNO) missed the analysts' consensus estimate of ($4.69) by $0.68 with a reported earnings per share (EPS) of ($5.37). Learn more on analysts' earnings estimate vs. NVNO's actual earnings.

enVVeno Medical (NASDAQ:NVNO) has a recorded net income of -$19.47 million. NVNO has generated -$19.33 earnings per share over the last four quarters.

enVVeno Medical's earnings are expected to grow from ($16.19) per share to ($6.22) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:NVNO is sourced from Fiscal.ai, with the most recent quarter reported on 7/30/2026. New results are added as companies report their earnings.
From Our Partners
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
Your Free Report (Inside)
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
23,281 stocks. Only ONE survived.
One American energy producer just cleared a screen of 23281 stocks for elite operating profits, double-digit r...
Monument Traders Alliance | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
Someone just dumped the biggest gold fund.
Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...
Behind the Markets | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel